Toward Biomarker Development in Large Clinical Cohorts: An Integrated High-Throughput 96-Well-Plate-Based Sample Preparation Workflow for Versatile Downstream Proteomic Analyses.

We describe a cheap, robust, fast, high-throughput, and flexible proteomic sample processing method based on a regular 96-well plate by acetone precipitation under low centrifuge speed (96PACS), which enables predigestion processing of 96 samples within 2 h. Tested on a complex Huh-7 total lysate, 96PACS produced comparable proteome coverage and even showed better reproducibility than FASP. Quantitative performance of 96PACS was further tested using data-independent acquisition and parallel reaction monitoring quantitation in a set of 6 benchmark samples consisting of 6 serial dilutions of BSA spiked in complex E. coli proteome background. The protocol was also successfully modified for automation and was validated in a comparative label-free proteomic study to develop serum markers for early detection of liver fibrosis and necroinflammation in patients chronically infected with hepatitis B virus.

[1]  N. Terrault,et al.  AASLD guidelines for treatment of chronic hepatitis B , 2016, Hepatology.

[2]  M. Kussmann,et al.  Proteomics of Cerebrospinal Fluid: Throughput and Robustness Using a Scalable Automated Analysis Pipeline for Biomarker Discovery. , 2015, Analytical chemistry.

[3]  H. Steen,et al.  MStern Blotting–High Throughput Polyvinylidene Fluoride (PVDF) Membrane-Based Proteomic Sample Preparation for 96-Well Plates* , 2015, Molecular & Cellular Proteomics.

[4]  H. Chan,et al.  Hepatitis B virus infection , 2014, The Lancet.

[5]  Brendan MacLean,et al.  MSstats: an R package for statistical analysis of quantitative mass spectrometry-based proteomic experiments , 2014, Bioinform..

[6]  M. Kussmann,et al.  Comprehensive and Scalable Highly Automated MS-Based Proteomic Workflow for Clinical Biomarker Discovery in Human Plasma. , 2014, Journal of proteome research.

[7]  R. Yantiss,et al.  FibroSURE as a noninvasive marker of liver fibrosis and inflammation in chronic hepatitis B , 2014, BMC Gastroenterology.

[8]  K. Nelson,et al.  Urine Sample Preparation in 96-Well Filter Plates for Quantitative Clinical Proteomics , 2014, Analytical chemistry.

[9]  M. Cheng,et al.  Comparison of Histologic Characteristics of Chinese Chronic Hepatitis B Patients with Persistently Normal or Mildly Elevated ALT , 2013, PloS one.

[10]  Martijn Pinkse,et al.  A high‐throughput sample preparation method for cellular proteomics using 96‐well filter plates , 2013, Proteomics.

[11]  Ruedi Aebersold,et al.  Automated selected reaction monitoring data analysis workflow for large-scale targeted proteomic studies , 2013, Nature Protocols.

[12]  H. Wang,et al.  Comparison of FIB‐4 and APRI in Chinese HBV‐infected patients with persistently normal ALT and mildly elevated ALT , 2013, Journal of viral hepatitis.

[13]  Ruedi Aebersold,et al.  Statistical protein quantification and significance analysis in label-free LC-MS experiments with complex designs , 2012, BMC Bioinformatics.

[14]  Fu-Bing Wang,et al.  HBV inhibits apoB production via the suppression of MTP expression , 2011, Lipids in Health and Disease.

[15]  M. Mann,et al.  Universal sample preparation method for proteome analysis , 2009, Nature Methods.

[16]  Y. Liaw,et al.  Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update , 2008, Hepatology international.

[17]  S. Wold,et al.  Orthogonal projections to latent structures (O‐PLS) , 2002 .

[18]  P. Bedossa,et al.  Alpha-2-macroglobulin and hepatic fibrosis , 1994, Digestive Diseases and Sciences.

[19]  Jörg Petersen,et al.  EASL Clinical Practice Guidelines: management of chronic hepatitis B. , 2009, Journal of hepatology.